The Cardiopulmonary Autotransfusion Devices Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Cardiopulmonary Autotransfusion Devices Market : Drivers and Challenges
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems. This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems. Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.
The global cardiopulmonary autotransfusion devices market is expected to show significant growth over the forecast period. In 2015, World Health Organization (WHO) estimated that cardiac disorder accounted for around 450,000 deaths in the U.S. each year. This factor is considered as the world leading factor for death. This has impelled both government and research institution to focus on innovation of cardiopulmonary autotransfusion devices for betterment of heart health among citizens.
Based on product type cardiopulmonary devices market has been segmented as on- pump transfusion and off-pump transfusion. On pump transfusion is expected to hold maximum share in pulmonary auto transfusion market. Based on end user, the global cardiopulmonary autotransfusion market has been classified as hospitals, ambulatory surgical centers and cardiac research centers. Hospitals end user segment is expected to hold maximum share in the global market owing to requirement of advanced healthcare infrastructure for the cardiac surgery.
Cardiopulmonary Autotransfusion Devices Market : Regional Overview
On the basis of region, global cardio pulmonary devices market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to dominate the global cardiopulmonary autotransfusion market due to high incidence of the cardiac diseases. North America market is followed by Europe. In Asia Pacific region India and China is expected to show high growth due to increasing investment in the auto transfusion market.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12067
Cardiopulmonary Autotransfusion Devices Market : Key Players
Some of the key players of cardiopulmonary autotransfusion market are Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo Corporation, Stryker and Atrium Medical.
Browse Full Report summary and to request sample report and table of content@ http://www.persistencemarketresearch.com/market-research/cardiopulmonary-autotransfusion-devices-market.asp
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353